Recall issued for MAR-Amlodipine in Canada after some bottles were found to contain a different medication
Latest news on WhatsApp أجدد الأخبار على واتساب
Health Canada has recalled two lots of MAR-Amlodipine 5 mg after some bottles were found to contain the wrong tablets, identified as midodrine 2.5 mg instead of the prescribed blood pressure medication. The advisory applies to lots 2472021 and 2472021A, with an expiry date of July 2027.
MAR-Amlodipine is used to treat high blood pressure and chest pain, while midodrine is used to treat low blood pressure. Health Canada warned that taking midodrine by mistake could lead to serious side effects, including dangerously high blood pressure, dizziness, fainting, slow heartbeats, and possible organ damage.
The correct MAR-Amlodipine tablets are described as white to off-white, flat, and eight-sided, with “210” and “5” printed on one side. The wrong tablets are white, round, and marked “M2.” Health Canada advised patients to check their bottles immediately, return any suspicious product to their pharmacy, and seek medical attention right away if they experience symptoms such as chest pain, unusual dizziness, impaired speech, or sudden weakness.
The recall remains an important health alert for Canadians who follow medication safety notices, especially for drugs used in blood-pressure treatment, where a mix-up in the bottle can have direct and immediate consequences for patients.
You May Also Like
Authors
-
Tahani Elghazaly5252 Posts
